Several effects have been associated with DPP-4, including degradation of various substrates (such as incretins, neuropeptides, and cytokines) and involvement with inflammatory processes (including cancer, obesity, and T2DM, 20, 37)
Common options include weekly injections such as semaglutide and tirzepatide
I break this down in more detail in this blog post on changes in body composition during menopause
Further research, especially clinical trials, is also required in this area (Sweeney et al
It's also important to monitor for signs of dehydration that could lead to acute kidney injury, and to be alert to any visual changes (possible retinopathy) or severe abdominal pain (possible pancreatitis)